SCHEMBL9344729

SCHEMBL9344729

CC(C)ON=C(C(=O)O)c1csc(NC(c2ccccc2)(c2ccccc2)c2ccccc2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.46
GAA P10253 5/20 0.46
LMNA P02545 3/20 0.46
KMT2A Q03164 7/20 0.39
MEN1 O00255 6/20 0.39
NPSR1 Q6W5P4 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
RECQL P46063 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
POLB P06746 2/20 0.37
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9623442 1.00 MAPT (0.46) MAPTGAALMNAKMT2AMEN1
SCHEMBL9344725 1.00 MAPT (0.46) MAPTGAALMNAKMT2AMEN1
SCHEMBL11311721 0.91 POLB (0.38) MAPTGAALMNAKMT2AMEN1
SCHEMBL11311725 0.91 MAPT (0.39) MAPTGAALMNAKMT2AMEN1
SCHEMBL8843840 0.91 MAPT (0.44) MAPTGAALMNAKMT2AMEN1
SCHEMBL11311717 0.91 POLB (0.38) MAPTGAALMNAKMT2AMEN1
SCHEMBL9021455 0.91 MAPT (0.44) MAPTGAALMNAKMT2AMEN1
SCHEMBL15500658 0.91 MAPT (0.44) MAPTGAALMNAKMT2AMEN1
SCHEMBL9344746 0.90 MAPT (0.39) MAPTGAALMNAKMT2AMEN1
SCHEMBL9344751 0.90 MAPT (0.39) MAPTGAALMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5336776-A Cephalopsporin intermediates; Staphyloccus septicemia and skin disorders; penicillin-resistant gramnegative bacteria ROUSSEL UCLAF (FR) 1994-08-09 US disclosed
US-5103012-A Chemical intermediate ROUSSEL UCLAF (FR) 1992-04-07 US disclosed
EP-0238060-B1 CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS Banyu Pharmaceutical Co., Ltd. (JP) 1992-01-08 EP disclosed
US-4988816-A Chemical intermediates for cephalosporin antibiotics ROUSSEL UCLAF (FR) 1991-01-29 US disclosed
EP-0121244-B1 CEPHALOSPORIN DERIVATIVES Bristol-Myers Company (US) 1990-09-12 EP disclosed
US-4843164-A CEPHALOSPORIN INTERMEDIATE; ANTIBIOTIC ROUSSEL UCLAF (FR) 1989-06-27 US disclosed
US-4814328-A Cephalosporin derivatives, and antibacterial agents BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-03-21 US disclosed
US-4782155-A ISOQUINOLINE SALTS BANYU PHARMACEUTICAL CO., LTD. (JP) 1988-11-01 US disclosed
EP-0238060-A2 Cephalosporin derivatives, processes for their preparation and antibacterial agents Banyu Pharmaceutical Co., Ltd. (JP) 1987-09-23 EP disclosed
US-4576938-A Cephalosporin compound and process for preparing the same TANABE SEIYAKU CO., LTD. (JP) 1986-03-18 US disclosed
US-4525473-A BACTERICIDES BRISTOL-MYERS COMPANY (US) 1985-06-25 US disclosed
EP-0121244-A2 Cephalosporin derivatives Bristol-Myers Company (US) 1984-10-10 EP disclosed
US-4406899-A Cephalosporins BRISTOL-MYERS COMPANY (US) 1983-09-27 US disclosed
EP-0081971-A2 Novel cephalosporin compound and process for preparing the same Tanabe Seiyaku Co., Ltd. (JP) 1983-06-22 EP disclosed
US-4376203-A ANTIBIOTIC ROUSSELL UCLAF (FR) 1983-03-08 US disclosed
US-4283396-A 3-Acetoxymethyl-7-(hydroxyiminoacetamido)-cephalosporanic acid derivatives ROUSSEL UCLAF (FR) 1981-08-11 US disclosed
US-4196205-A ANTIBIOTICS, BACTERICIDES ROUSSEL UCLAF (FR) 1980-04-01 US disclosed
US-4152432-A ANTIBIOTICS ROUSSEL UCLAF (FR) 1979-05-01 US disclosed